0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessM. Brahmi, Camille Schiffler, M. Toulmonde, Thibaud Valentin, Agnès Ducoulombier, Christophe Perrin, N. Penel, Isabelle Desmoulins, C. Tlemsani, François Bertucci, Justine Gantzer, Nicolás Isambert, L. Chaigneau, Isabelle Laure Ray-Coquard, Séverine Metzger, David Pérol, Jean Yves Blay, A. Dufresne (2025). LBA98 Final results of the RAR-IMMUNE study: A randomized, comparative, prospective, multicenter phase III trial of the efficacy of nivolumab + ipilimumab (N+I) versus pazopanib (P) in patients (pt) with advanced sarcoma (S) of rare subtype. , 36, DOI: https://doi.org/10.1016/j.annonc.2025.09.115.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
18
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1016/j.annonc.2025.09.115
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
